Our N-methyl-4-nitro-Benzenamine is a high-quality chemical compound that is widely used in the pharmaceutical industry. With a minimum purity of 98.5% as measured by HPLC, our product meets the strictest quality standards. We provide a comprehensive set of documentation, including a Certificate of Analysis (COA), Nuclear Magnetic Resonance (NMR), HPLC, Material Safety Data Sheet (MSDS), Reactive Oxygen Species (ROS), and Dimethylformamide (DMF), ensuring transparency and reliability in our product.
In addition to providing high-quality N-methyl-4-nitro-Benzenamine, we offer three key services to support new drug applications:
Our pharmaceutical-grade compound, N-methyl-4-nitro-Benzenamine, also recognized by IUPAC as 4-Nitroaniline, is an essential ingredient in Selective Androgen Receptor Modulators. Verified by High-Performance Liquid Chromatography (HPLC), its purity level is an impressive 98.5% making it a reliable component in scientific research and new drug development.
Backed up by our mature, repeatable pilot process with independent intellectual property rights, the high purity grade of N-methyl-4-nitro-Benzenamine is ideally suited for pharmaceutical companies. We also offer a thorough study of its impurity.
We provide extensive documentation for complete product understanding and usage including Certificate of Analysis (COA), Nuclear Magnetic Resorance (NMR), HPLC reports, Material Safety Data Sheet (MSDS), Reactive Oxygen Species (ROS) information, and Dimethylformamide (DMF) data.
Please take into consideration that these product details are not exhaustive and must be cross-checked with authoritative databases for verification. Failing to do so may have severe consequences. This information should not be used as the only reference point for research or medicinal applications.
The pharmaceutical-grade compound N-methyl-4-nitro-Benzenamine by our company enjoys a robust presence across different regions such as North America, Central/South America, Western & Eastern Europe, Australasia, Asia, and the Middle East. As of the current situation, no samples are being provided.